Ono Pharmaceutical has claimed FDA approval for Romvimza as a treatment for tenosynovial giant cell tumour (TGCT), setting up a market tussle with Daiichi Sankyo. CSF-1R inhibitor Romvimza ...

This week brings a mix of goodbyes, hellos, and plenty of exciting updates—and that's just the beginning! From Downtown Disney buzzing with new tenants ...